Ron Zuckerman

Ron Zuckerman has been active as a tech entrepreneur and investor for most of the last 25 years. He was one of the founders of Sapiens International, a software company he took public on NASDAQ in 1990 andis currently trading with a market cap of over $700m. Mr Zuckerman acted as chair and chief executive of Sapiens from early 1995 to late 1999. He was the founder and executive chair of Precise Software Solutions, another software company he took public on NASDAQ in 2000 until its acquisition in late 2003 by VERITAS, in a cash transaction valued at over $600 Million. Mr Zuckerman was a founder, first round investor and a board member in GVT Holding SA, a large telephone operator in Brazil, until its acquisition in late 2009 by The Vivendi Group of France for over $4.7 Billion. He was an early investor and a board member at Wintegra, which was acquired in 2010 by PMC Sierra for over $200m. In 2000, Mr Zuckerman was chosen by the World Economic Forum as leading one of the most influential tech ventures (ie Sapiens), together with such individuals as Masayoshi Son of SoftBank Group, Jerry Yang of Yahoo! and Michael Dell of Dell Computers.
Bio last updated 15 Apr 2017

Access to our data for Ron Zuckerman is only available to paid subscribers with access.

The search engine is Western Australia's most accurate and comprehensive business listings and searchable database.

Ron Zuckerman is linked to 1 organisation which is included in 2 lists - Technology Companies and Public Companies - Industrial.

To see the data you will need to .

Total Shareholder Return as at 31/10/18

1 year TSR5 year TSR
9thBARD1 Life Sciences445%10%
148thDragontail Systems33%0%
514thMGC Pharmaceuticals-25%36%
826thServtech Global Holdings-80%0%
744 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar


Non-Executive Director
Year started and most recent title


183rd-Servtech Global Holdings$430k
184th↓Dragontail Systems$419k
185th↓MGC Pharmaceuticals$403k
186th↑BARD1 Life Sciences$365k
240 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer